Skip to main content
Fig. 1 | Trials

Fig. 1

From: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial

Fig. 1

Flow chart of the study design. POAG primary open-angle glaucoma, RNFL retinal nerve fiber layer, GCIPL ganglion cell inner plexiform layer, GPA Guided Progression Analysis, TPA Trend-based Progression Analysis, EMGT Early Manifest Glaucoma Trial, IOP intraocular pressure, VF visual field, OCT optical coherence tomography, NR nicotinamide riboside

Back to article page

Trials

ISSN: 1745-6215